Medical Journals

Chemokine and Chemokine Receptor Expression During Colony Stimulating Factor-1-induced Osteoclast Differentiation in the Toothless Osteopetrotic Rat: a Key Role for Ccl9 (Mip-1gamma) in Osteoclastogenesis in Vivo and in Vitro.

Authors:
  • Yang Meiheng
  • Mailhot Geneviève
  • MacKay Carole A
  • Mason-Savas April
  • Aubin Justin
  • Odgren Paul R

From: Dept of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655, USA.

Blood

  • Publish Date: Mar 2006
  • ISSN: 0006-4971
  • Volume: 107
  • Issue: 6
  • Pages: 2262-70
  • Medium: Print
  • Language: English
  • Citation (JAMA): Yang Meiheng, Mailhot Geneviève, MacKay Carole A, et al. Chemokine and Chemokine Receptor Expression During Colony Stimulating Factor-1-induced Osteoclast Differentiation in the Toothless Osteopetrotic Rat: a Key Role for Ccl9 (Mip-1gamma) in Osteoclastogenesis in Vivo and in Vitro.. Blood Mar 2006;107:2262-70

Abstract

Osteoclasts differentiate from hematopoietic precursors under systemic and local controls. Chemokines and receptors direct leukocyte traffic throughout the body and may help regulate site-specific bone resorption. We investigated bone gene expression in vivo during rapid osteoclast differentiation induced by colony-stimulating factor 1 (CSF-1) in Csf1-null toothless (tl/tl) rats. Long-bone RNA from CSF-1-treated tl/tl rats was analyzed by high-density microarray over a time course. TRAP (tartrate-resistant acid phosphatase)-positive osteoclasts appeared on day 2, peaked on day 4, and decreased slightly on day 6, as marrow space was expanding. TRAP and cathepsin K mRNA paralleled the cell counts. We examined all chemokine and receptor mRNAs on the arrays. CCL9 was strongly induced and peaked on day 2, as did its receptor, CCR1, and regulatory receptors c-Fms (CSF-1 receptor) and RANK (receptor activator of nuclear factor kappaB). Other chemokines and receptors showed little or no significant changes. In situ hybridization and immunohistochemistry revealed CCL9 in small, immature osteoclasts on day 2 and in mature cells at later times. Anti-CCL9 antibody inhibited osteoclast differentiation in culture and significantly suppressed the osteoclast response in CSF-1-treated tl/tl rats. While various chemokines have been implicated in osteoclastogenesis in vitro, this first systematic analysis of chemokines and receptors during osteoclast differentiation in vivo highlights the key role of CCL9 in this process.

Mesh Headings (Keywords): Animals, Cathepsins, Cell Differentiation, Cell Proliferation, Chemokines, CC, Gene Expression Profiling, Glycoproteins, Macrophage Colony-Stimulating Factor, Macrophage Inflammatory Proteins, Osteoclasts, Osteopetrosis, Osteoprotegerin, RNA, Rats, Rats, Inbred Strains, Receptor, Macrophage Colony-Stimulating Factor, Receptors, CCR1, Receptors, Chemokine, Receptors, Cytoplasmic and Nuclear, Receptors, Tumor Necrosis Factor


Check for Full Text / PubMed Unique Identifier (PMID): 16304045


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.